Drug
Cabamiquine clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
4 studies that test it; most in 2023 (2)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (3) · Merck KGaA, Darmstadt, Germany (1)
Often tested with
Tested in the same studies.
Pyronaridine (2) · Atovaquone, proguanil drug combination (1)
Studies
Open first, then newest update. How each study uses cabamiquine is read from its arms, and is right about nine times in ten.
Testing it · 4
- Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)CompletedPhase 2Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT05974267Written as M5717 60 mg
- Phase IIa Proof of Concept Study of M5717-Pyronaridine in Adults and Adolescents With Acute Uncomplicated Plasmodium Falciparum Malaria (CAPTURE 1)CompletedPhase 2Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT05689047Written as M5717 330 mg
- Chemoprophylactic Activity of M5717 in PfSPZ Challenge ModelCompletedPhase 1Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT04250363Written as M5717 30 mg
- First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy ParticipantsCompletedPhase 1Merck KGaA, Darmstadt, GermanyNCT03261401Written as M5717
Codes
What other systems call cabamiquine · ClinicalTrials.gg INT016409
- UNII (FDA) E3OC1CU1F4CABAMIQUINEOne source FDA
- NCI Thesaurus C188567CabamiquineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | E3OC1CU1F4 | CABAMIQUINE | One source FDA |
| NCI Thesaurus | C188567 | Cabamiquine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.